1. P699: REAL-LIFE OUTCOMES OF PONATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) OR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (PH+ALL): 5-YEAR-DATA FROM A BELGIAN REGISTRY. (23rd June 2022) Authors: Devos, T.; Havelange, V.; Theunissen, K.; Meers, S.; Benghiat, F. S.; Gadisseur, A.; Vanstraelen, G.; Vellemans, H.; Bailly, B.; Granacher, N.; Lewalle, P.; De Becker, A.; Van Eygen, K.; Lejeune, M.; Janssen, M.; Triffet, A.; Vrelust, I.; Deeren, D.; Mazure, D.; Beck, M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗